Since the MMP-2 activity of cancer cells is associated with the potential for the invasion and metastasis of cancer cells (Figure 7b), inhibition of MMP-2 activity by treatment with AST or ChitoAST nanoparticles may affect the metastasis of B16F10 cells [54]. Here, MMP2 is linked to cancer.